In the new work, Shigeru Tajima, of the Japanese National Institute of Infectious Disease, and colleagues compared the PRVABC59 American subtype, the ZIKV/Hu/Chiba/S36/2016 (ChibaS36) Pacific subtype and the ZIKV/Hu/NIID123/2016 (NIID123) Southeast Asian subtype. They examined the growth rates both in vitro and in mice, and observed the viral loads and levels of testis damage in the infected mice. The PRVABC59 and ChibaS36 strains had significantly higher growth ability than NIID123 in multiple types of isolated cells, with the American strain having the highest growth potential. Moreover, two weeks post-infection, the amount of infectious particles and viral RNA in the genital tracts of male mice was lowest in those animals infected with the NIID123 strain. At 6 weeks post-infection, there was more testis damage in the mice infected with the American PRVABC59 stain.
"These results raise the possibility that ZIKV have acquired elevated proliferative capacity and pathogenicity during the process of the virus spreading from Southeast Asia to the Americas through the Pacific Islands," the researchers say.
Gamifying behavior change. Adherence and compliance represent crucial issues in improving patients’ health and decreasing the cost of delivering healthcare. Several start-ups have targeted this issue with different solutions such as a pill bottle that glows blue when a medication dose should be taken and red when a dose is missed (winner of the Healthcare Innovation World Cup); or tiny digestible sensors that can be placed in pills and can transmit pill digestion data to physicians and family members. While patients do not like the term adherence as they want to be partners with their caregivers rather than following orders, health insurance companies will use more and more data to check whether the patients comply with their prescriptions to decrease their insurance costs. The wildly popular Pokemon Go motivates people to walk more which might lead to fighting obesity while playing a game.